{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:35:18Z","timestamp":1792686918143,"version":"4.5.0"},"reference-count":73,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2025,7,20]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:p>Cardiovascular complications are increasingly recognised as a major driver of morbidity and early mortality in patients with sickle cell disease (SCD), yet they remain underdiagnosed and underappreciated. This contemporary review synthesises current knowledge across a spectrum of cardiovascular manifestations\u2014including myocardial dysfunction, pulmonary hypertension, cardiac iron overload, arrhythmias, myocardial infarction, stroke and sudden death\u2014with emphasis on their unique pathophysiological mechanisms in SCD. We highlight emerging diagnostic tools such as cardiac magnetic resonance with T2* mapping and extracellular volume sequences, speckle-tracking echocardiography and invasive exercise testing, which can revealing a distinct phenotype combining restrictive cardiomyopathy and high-output heart failure. Practical algorithms for risk stratification and disease monitoring are presented alongside evidence-based and SCD-specific management approaches, including the role of hydroxyurea, transfusions, anticoagulation and gene therapy. By integrating multimodality imaging, updated guideline recommendations and recent clinical insights, this review provides a comprehensive resource to support early recognition, personalised therapy and improved cardiovascular outcomes in SCD.<\/jats:p>","DOI":"10.1136\/heartjnl-2025-325837","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T07:55:22Z","timestamp":1754639722000},"page":"539-548","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Cardiovascular disease in Sickle cell: mechanisms, diagnostics and therapeutic advances"],"prefix":"10.1136","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6230-0031","authenticated-orcid":false,"given":"Elio","family":"Haroun","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9691-7258","authenticated-orcid":false,"given":"Aro Daniela","family":"Arockiam","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8480-3745","authenticated-orcid":false,"given":"Joseph","family":"El Dahdah","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kassab","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Nakhla","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Chedid El Helou","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsha","family":"Sanaka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2515-807X","authenticated-orcid":false,"given":"Ziad","family":"Zalaquett","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simrat","family":"Kaur","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabi","family":"Hanna","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology Oncology and Blood and Marrow Transplantation, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Griffin","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5570-9402","authenticated-orcid":false,"given":"Tom Kai Ming","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"2026042405501817000_112.10.539.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.10233"},{"key":"2026042405501817000_112.10.539.2","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.15585\/mmwr.mm6646a2","article-title":"CDC Grand Rounds: Improving the Lives of Persons with Sickle Cell Disease","volume":"66","author":"Hulihan","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026042405501817000_112.10.539.3","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/ajh.25202","article-title":"Clustering of end\u2010organ disease and earlier mortality in adults with sickle cell disease: A retrospective\u2010prospective cohort study","volume":"93","author":"Chaturvedi","year":"2018","journal-title":"American J Hematol"},{"key":"2026042405501817000_112.10.539.4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","year":"2013","journal-title":"The Lancet"},{"key":"2026042405501817000_112.10.539.5","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24557"},{"key":"2026042405501817000_112.10.539.6","first-page":"243","article-title":"Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease","volume":"9","author":"Niss","year":"2016","journal-title":"JACC: Cardiovascular Imaging"},{"key":"2026042405501817000_112.10.539.7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.013215"},{"key":"2026042405501817000_112.10.539.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2016.01.011"},{"key":"2026042405501817000_112.10.539.9","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1093\/ehjci\/jeab154","article-title":"Multimodality imaging in patients with heart failure and preserved ejection fraction: an expert consensus document of the European Association of Cardiovascular Imaging","volume":"23","author":"Smiseth","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026042405501817000_112.10.539.10","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2012-302346"},{"key":"2026042405501817000_112.10.539.11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-02-767624"},{"key":"2026042405501817000_112.10.539.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.09.038"},{"key":"2026042405501817000_112.10.539.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2014.10.003"},{"key":"2026042405501817000_112.10.539.14","doi-asserted-by":"publisher","DOI":"10.1002\/clc.22153"},{"key":"2026042405501817000_112.10.539.15","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000001063"},{"key":"2026042405501817000_112.10.539.16","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2021-319605"},{"key":"2026042405501817000_112.10.539.17","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2022-321097"},{"key":"2026042405501817000_112.10.539.18","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201401-0065ST"},{"key":"2026042405501817000_112.10.539.19","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2023-178267","article-title":"Myocardial Fibrosis Improves in Young Patients with Sickle Cell Disease after Hematopoietic Cell Transplantation","volume":"142","author":"Sharma","year":"2023","journal-title":"Blood"},{"key":"2026042405501817000_112.10.539.20","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/ajh.27522","article-title":"Effect of voxelotor on cerebral perfusion and cerebral oxygen metabolism and cardiac stress in adult patients with sickle cell disease","volume":"100","author":"Kont\u00e9","year":"2025","journal-title":"American J Hematol"},{"key":"2026042405501817000_112.10.539.21","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00879-2022"},{"key":"2026042405501817000_112.10.539.22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2147\/JBM.S455564","article-title":"Cardiovascular Consequences of Sickle Cell Disease","volume":"15","author":"Bahashwan","year":"2024","journal-title":"J Blood Med"},{"key":"2026042405501817000_112.10.539.23","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/ajh.21187","article-title":"Pulmonary arterial hypertension and left\u2010sided heart disease in sickle cell disease: Clinical characteristics and association with soluble adhesion molecule expression","volume":"83","author":"Klings","year":"2008","journal-title":"American J Hematol"},{"key":"2026042405501817000_112.10.539.24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-08-618561"},{"key":"2026042405501817000_112.10.539.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.10.029"},{"key":"2026042405501817000_112.10.539.26","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201606-1183ST"},{"key":"2026042405501817000_112.10.539.27","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00272-2018"},{"key":"2026042405501817000_112.10.539.28","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000916"},{"key":"2026042405501817000_112.10.539.29","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10184232","article-title":"Epidemiology of Stroke in Sickle Cell Disease","volume":"10","author":"Kirkham","year":"2021","journal-title":"J Clin Med"},{"key":"2026042405501817000_112.10.539.30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-09-618579"},{"key":"2026042405501817000_112.10.539.31","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(06)70469-0"},{"key":"2026042405501817000_112.10.539.32","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000375"},{"key":"2026042405501817000_112.10.539.33","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000046"},{"key":"2026042405501817000_112.10.539.34","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001142"},{"key":"2026042405501817000_112.10.539.35","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-09-551564"},{"key":"2026042405501817000_112.10.539.36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/ajh.21569","article-title":"Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease","volume":"85","author":"Fitzhugh","year":"2010","journal-title":"American J Hematol"},{"key":"2026042405501817000_112.10.539.37","article-title":"Understanding Sickle cell disease: Causes, symptoms, and treatment options","volume":"102","author":"Elendu","year":"2023","journal-title":"Medicine (Abingdon)"},{"key":"2026042405501817000_112.10.539.38","doi-asserted-by":"publisher","DOI":"10.1542\/peds.111.2.e183"},{"key":"2026042405501817000_112.10.539.39","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s12265-012-9426-z","article-title":"Myocardial Infarction in Sickle Cell Disease: Use of Translational Imaging to Diagnose an Under-Recognized Problem","volume":"6","author":"Chacko","year":"2013","journal-title":"J of Cardiovasc Trans Res"},{"key":"2026042405501817000_112.10.539.40","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2017.1.423"},{"key":"2026042405501817000_112.10.539.41","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1512021","article-title":"A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events","volume":"374","author":"Heeney","year":"2016","journal-title":"N Engl J Med"},{"key":"2026042405501817000_112.10.539.42","first-page":"448","article-title":"Myocardial infarction in sickle cell disease","volume":"94","author":"Mansi","year":"2002","journal-title":"J Natl Med Assoc"},{"key":"2026042405501817000_112.10.539.43","doi-asserted-by":"crossref","first-page":"592","DOI":"10.12688\/f1000research.22433.1","article-title":"Drug Therapies for the Management of Sickle Cell Disease","volume":"9","author":"Rai","year":"2020","journal-title":"F1000Res"},{"key":"2026042405501817000_112.10.539.44","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/ajh.23721","article-title":"Cardiac iron overload in sickle\u2010cell disease","volume":"89","author":"Meloni","year":"2014","journal-title":"American J Hematol"},{"key":"2026042405501817000_112.10.539.45","doi-asserted-by":"crossref","first-page":"560","DOI":"10.5114\/aoms.2017.68729","article-title":"Management of cardiac hemochromatosis","volume":"14","author":"Aronow","year":"2018","journal-title":"Aoms"},{"key":"2026042405501817000_112.10.539.46","doi-asserted-by":"publisher","DOI":"10.3109\/03630260903346627"},{"key":"2026042405501817000_112.10.539.47","doi-asserted-by":"crossref","first-page":"132616","DOI":"10.1016\/j.ijcard.2024.132616","article-title":"Speckle-tracking echocardiography as screening tool for myocardial fibrosis and Iron overload in transfusion-dependent beta-thalassemia","volume":"418","author":"Guaricci","year":"2025","journal-title":"Int J Cardiol"},{"key":"2026042405501817000_112.10.539.48","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10554-020-01949-8","article-title":"Early detection of ventricular dysfunction by tissue Doppler echocardiography related to cardiac iron overload in patients with thalassemia","volume":"37","author":"Silvilairat","year":"2021","journal-title":"Int J Cardiovasc Imaging"},{"key":"2026042405501817000_112.10.539.49","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1007\/s10554-022-02597-w","article-title":"Cardiac iron overload detection using longitudinal strain in asymptomatic children with beta thalassemia major","volume":"38","author":"Chamtouri","year":"2022","journal-title":"Int J Cardiovasc Imaging"},{"key":"2026042405501817000_112.10.539.50","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2001.2822"},{"key":"2026042405501817000_112.10.539.51","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/bjh.14575","article-title":"How we manage iron overload in sickle cell patients","volume":"177","author":"Coates","year":"2017","journal-title":"Br J Haematol"},{"key":"2026042405501817000_112.10.539.52","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001143"},{"key":"2026042405501817000_112.10.539.53","doi-asserted-by":"publisher","DOI":"10.1002\/joa3.12418"},{"key":"2026042405501817000_112.10.539.54","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/clc.4960060707","article-title":"Continuous electrocardiographic monitoring in patients with sickle\u2010cell anemia during pain crisis","volume":"6","author":"Maisel","year":"1983","journal-title":"Clin Cardiol"},{"key":"2026042405501817000_112.10.539.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.03.083"},{"key":"2026042405501817000_112.10.539.56","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020005944"},{"key":"2026042405501817000_112.10.539.57","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1182\/blood.2022019571","article-title":"Determinants of ventricular arrhythmias in sickle cell anemia: toward better prevention of sudden cardiac death","volume":"142","author":"d\u2019Humi\u00e8res","year":"2023","journal-title":"Blood"},{"key":"2026042405501817000_112.10.539.58","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.029788","article-title":"Atrial Fibrillation Catheter Ablation and Rhythm Control in Patients With Sickle Cell Disorders: A Propensity Score\u2013Matched Analysis","volume":"13","author":"Gier","year":"2024","journal-title":"JAHA"},{"key":"2026042405501817000_112.10.539.59","doi-asserted-by":"crossref","first-page":"16437","DOI":"10.1038\/s41598-022-20955-5","article-title":"Amiodarone improves anemia in a murine model of sickle cell disease and is associated with increased erythrocyte bis(monoacylglycerol) phosphate","volume":"12","author":"Venugopal","year":"2022","journal-title":"Sci Rep"},{"key":"2026042405501817000_112.10.539.60","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2018-99-119860","article-title":"Sudden Death in Sickle Cell Disease: An Assessment of Risk Factors","volume":"132","author":"Nze","year":"2018","journal-title":"Blood"},{"key":"2026042405501817000_112.10.539.61","unstructured":"ASH position on sickle cell trait - hematology.org. 2025 Available: https:\/\/www.hematology.org\/advocacy\/policy-statements\/2021\/ash-position-on-sickle-cell-trait"},{"key":"2026042405501817000_112.10.539.62","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035477"},{"key":"2026042405501817000_112.10.539.63","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ajh.21699","article-title":"The risks and benefits of long\u2010term use of hydroxyurea in sickle cell anemia: A 17.5 year follow\u2010up","volume":"85","author":"Steinberg","year":"2010","journal-title":"American J Hematol"},{"key":"2026042405501817000_112.10.539.64","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-013-0895-y"},{"key":"2026042405501817000_112.10.539.65","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00647-4"},{"key":"2026042405501817000_112.10.539.66","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2117175"},{"key":"2026042405501817000_112.10.539.67","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2309676"},{"key":"2026042405501817000_112.10.539.68","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/hematology.2023000487","article-title":"Gene therapy for sickle cell disease","volume":"2023","author":"Leonard","year":"2023","journal-title":"Hematology"},{"key":"2026042405501817000_112.10.539.69","doi-asserted-by":"crossref","unstructured":"Yassin M , Minniti C , Shah N , et al . Evidence and gaps in clinical outcomes of novel pharmacologic therapies for sickle cell disease: A systematic literature review highlighting insights from clinical trials and real-world studies. Blood Rev 2025;101298. doi:10.1016\/j.blre.2025.101298","DOI":"10.1016\/j.blre.2025.101298"},{"key":"2026042405501817000_112.10.539.70","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2013.01.055"},{"key":"2026042405501817000_112.10.539.71","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27113","article-title":"Diastolic dysfunction is associated with exercise impairment in patients with sickle cell anemia","volume":"65","author":"Alsaied","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"2026042405501817000_112.10.539.72","doi-asserted-by":"publisher","DOI":"10.1186\/1532-429X-15-83"},{"key":"2026042405501817000_112.10.539.73","first-page":"430","article-title":"Mechanistic Insights and Characterization of Sickle Cell Disease\u2013Associated Cardiomyopathy","volume":"7","author":"Desai","year":"2014","journal-title":"Circ: Cardiovascular Imaging"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2025-325837","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T12:50:41Z","timestamp":1777035041000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2025-325837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":73,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,4,24]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1136\/heartjnl-2025-325837"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2025-325837","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]}}}